The invention relates to the field of pharmaceutical formulations, and in particular relates to a traditional Chinese medicine for treating coronary heart disease. The traditional Chinese medicine is characterized by being prepared from the following raw medicines in parts by weight: 20 to 40 parts of pubescent holly root, 7 to 13 parts of ziziphora clinopodioides, 5 to 7 parts of red rhodobryum, 10 to 20 parts of fuscoporia punctata, 12 to 18 parts of semen cassia, 10 to 20 parts of humifuse euphorbia herb, 12 to 18 parts of notopterygium root, 6 to 14 parts of ardisiae japonica, 15 to 25 parts of storax, 10 to 20 parts of acorus calamus, 15 to 25 parts of woody-rhizomed fimbristylis herb, 10 to 20 parts of radix bupleuri, 12 to 18 parts of humulus scandens, 15 to 25 parts of semen lepidii, 5 to 13 parts of zornia gibbosa, 8 to 16 parts of trichosanthes kiritowii maxim, 15 to 25 parts of eucommia ulmoides, 15 to 25 parts of cynanchum paniculatum, and 15 to 25 parts of alpinia katsumadai. The traditional Chinese medicine is prepared by soaking the nineteen raw medicines with water, then decocting, and removing the leaves to obtain the filtrate. According to the traditional Chinese medicine for treating coronary heart disease, all raw medicines are coordinated to act to realize the effects of effectively treating coronary heart disease and cardiovascular blockage, the treatment effect is accurate, the recovery rate is high, and any toxic and side effects are not caused.